“Most of this year’s nominees were developed by studios in-house, appearing to validate a renewed willingness in Hollywood to risk money on films that have little hope of breaking the $100 million ticket-sales barrier.”
“Most of this year’s nominees were developed by studios in-house, appearing to validate a renewed willingness in Hollywood to risk money on films that have little hope of breaking the $100 million ticket-sales barrier.”